Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar� Palatal Implant System � a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) to sleep better and feel better � today announced that its president and chief executive officer, Bob Paulson, will present at the upcoming Rodman & Renshaw Eighth Annual Healthcare Conference. The presentation is scheduled for 9:10 AM (Eastern Time) on Wednesday, November 8, 2006. The event will be held from November 6-8, 2006 at the New York Palace Hotel in New York. Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Restore Medical�s web site, www.restoremedical.com a few minutes prior to start time to download any necessary software. The presentation will be archived for one year. The conference will feature presentations from more than 290 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding the conference can be obtained at www.rodmanandrenshaw.com. About Restore Medical and the Pillar Procedure Restore Medical develops, manufactures and markets innovative medical devices to treat sleep-disordered breathing. The Company's proprietary Pillar� Palatal Implant System is the only implantable palatal device to treat snoring and mild-to-moderate obstructive sleep apnea to be approved by the U.S. Food and Drug Administration and Health Canada, and to have received the CE Mark for sale in the European Union. The Pillar Palatal Implant System is sold throughout the U.S. and Canada, and in various countries in Asia Pacific, Europe, South America and the Middle East. Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal Implant System - a simple, minimally-invasive treatment to help individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) to sleep better and feel better - today announced that its president and chief executive officer, Bob Paulson, will present at the upcoming Rodman & Renshaw Eighth Annual Healthcare Conference. The presentation is scheduled for 9:10 AM (Eastern Time) on Wednesday, November 8, 2006. The event will be held from November 6-8, 2006 at the New York Palace Hotel in New York. Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Restore Medical's web site, www.restoremedical.com a few minutes prior to start time to download any necessary software. The presentation will be archived for one year. The conference will feature presentations from more than 290 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding the conference can be obtained at www.rodmanandrenshaw.com. About Restore Medical and the Pillar Procedure Restore Medical develops, manufactures and markets innovative medical devices to treat sleep-disordered breathing. The Company's proprietary Pillar(R) Palatal Implant System is the only implantable palatal device to treat snoring and mild-to-moderate obstructive sleep apnea to be approved by the U.S. Food and Drug Administration and Health Canada, and to have received the CE Mark for sale in the European Union. The Pillar Palatal Implant System is sold throughout the U.S. and Canada, and in various countries in Asia Pacific, Europe, South America and the Middle East.
Grafico Azioni Restore Medical (MM) (NASDAQ:REST)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Restore Medical (MM)
Grafico Azioni Restore Medical (MM) (NASDAQ:REST)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Restore Medical (MM)